China 
Africa 
Explore chapters and articles related to this topic
Reduction and Fixation of Sacroiliac joint Dislocation by the Combined Use of S1 Pedicle Screws and an Iliac Rod
Published in Kai-Uwe Lewandrowski, Donald L. Wise, Debra J. Trantolo, Michael J. Yaszemski, Augustus A. White, Advances in Spinal Fusion, 2003
Kai-Uwe Lewandrowski, Donald L. Wise, Debra J. Trantolo, Michael J. Yaszemski, Augustus A. White
Kyphoplasty and vertebroplasty are contraindicated in stable, healed, nonpainful fractures and in the presence of infection. Concomitant medical problems can make surgery and anesthesia dangerous. In patients with clotting disorders, epidural hematoma may result from VB cannula-tion, particularly if the pedicle borders, or posterior VB, have been violated. Though some surgeons have performed kyphoplasty in patients with osteoporotic burst fractures, it is the authors’ opinion that this is a relative contraindication to either procedure. Fractures with severe VB height loss, as occurs with severe vertebra plana, may not be amenable to vertebral augmentation because of the inability to cannulate the VB. PREOPERATIVE PLANNING
Biomechanical comparison of vertebral augmentation and cement discoplasty for the treatment of symptomatic Schmorl’s node: a finite element analysis
Published in Computer Methods in Biomechanics and Biomedical Engineering, 2022
Kaiwen Cai, Zhang Zhang, Kefeng Luo, Feng Cao, Bin Lu, Yuanhua Wu, Hongxia Wang, Kai Zhang, Guoqiang Jiang
In 2006, Masala et al. first reported the use of percutaneous vertebroplasty (PVP) for treating symptomatic Schmorl’s nodes (Masala et al. 2006). Soon thereafter, several researchers began experimenting with percutaneous vertebral augmentation (PVA), including PVP and percutaneous kyphoplasty (PKP), to treat this disease. PVA surgery is able to provide rapid pain relief and significant capacity improvement, which is well maintained in long-term follow-up (He et al. 2017; Amoretti et al. 2019; Zhi-Yong et al. 2017; Masala et al. 2014). In 2015, an alternative surgical approach referred to as either percutaneous cement discoplasty (PCD) or percutaneous disc cementoplasty (PDC) was first reported by Varga et al. (2015). This procedure was initially used to treat the disc vacuum phenomenon caused by severe degeneration of the disc, as well as vertical instability syndromes, such as secondary foramen stenosis. More recently, this technique has been introduced in the treatment of symptomatic Schmorl’s nodes, with satisfactory results (Tian et al. 2017, 2019; Kiss et al. 2019). However, the evidences of these two novel technologies have been based on case series reports, with few reports of surgical-related complications. High-quality evidence regarding the safety and efficacy of these methods are therefore lacking due to the small sample sizes and high risk for conclusion bias associated with this type of research. To the best of our knowledge, no controlled studies have investigated the use of either method to date.